Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.3474
+0.0177 (5.37%)
At close: Apr 8, 2026, 4:00 PM EDT
0.3400
-0.0074 (-2.13%)
After-hours: Apr 8, 2026, 7:46 PM EDT

Gossamer Bio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
37.7346.0732.11111.97183.4
Short-Term Investments
99.2248.44264.32143.71141.82
Cash & Short-Term Investments
136.93294.52296.43255.68325.22
Cash Growth
-53.51%-0.64%15.94%-21.38%-36.56%
Other Receivables
12.235.34---
Total Trade Receivables
12.235.34---
Other Current Assets
18.4910.0310.096.26.56
Total Current Assets
167.64309.89306.52261.88331.78
Net Property, Plant & Equipment
4.25.124.789.8910.8
Other Long-Term Assets
0.410.280.620.681.08
Total Assets
172.25315.29311.92272.45343.66
Accounts Payable
5.962.325.531.463.24
Accrued Expenses
37.4925.6434.4636.1636.62
Current Portion of Long-Term Debt
--11.6111.61-
Unearned Revenue
19.9917.05---
Total Current Liabilities
63.4445.0151.649.2339.86
Long-Term Debt
198.51197.52197.41207.7179.12
Long-Term Leases
3.464.40.143.453.22
Other Long-Term Liabilities
29.6138.87---
Total Long-Term Liabilities
231.57240.79197.55211.14182.34
Total Liabilities
295.01285.8249.15260.37222.19
Common Stock
0.020.020.020.010.01
Additional Paid-in Capital
1,3211,2971,2751,045932.94
Accumulated Other Comprehensive Income
-5.151.19-0.35-0.570.05
Retained Earnings
-1,439-1,269-1,212-1,032-811.53
Shareholders' Equity
-122.7629.4962.7712.08121.46
Total Liabilities & Equity
172.25315.29311.92272.45343.66
Total Debt
201.97201.92209.16222.76182.34
Net Cash (Debt)
-65.0492.687.2632.92142.88
Net Cash Growth
-6.11%165.06%-76.96%-57.03%
Net Cash Per Share
-0.280.410.570.391.91
Book Value
-122.7629.4962.7712.08121.46
Book Value Per Share
-0.540.130.410.141.62
Tangible Book Value
-122.7629.4962.7712.08121.46
Tangible Book Value Per Share
-0.540.130.410.141.62
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q